Recent Updates
Recently added Catalysts

ORBIMED ADVISORS LLC

Track ORBIMED ADVISORS LLC's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Jun 19, 2026
Showing 6 Stocks Out Of 113. Click On The Tickers For More Details
Stock Compnay Name Shares Held Market Value % of Portfolio QoQ Change
BCRX
BCRX
BIOCRYST PHARMACEUTICALS INC
1.43 M
13.57 M
0.3
TECX
TECX
TECTONIC THERAPEUTIC INC
226.60 K
7.00 M
0.1
AVTX
AVTX
AVALO THERAPEUTICS INC
475.17 K
7.09 M
0.1
HRTX
HRTX
HERON THERAPEUTICS INC
9.82 M
7.85 M
0.2
GILD
GILD
GILEAD SCIENCES INC
59.60 K
8.31 M
0.2
KROS
KROS
KEROS THERAPEUTICS INC
759.15 K
8.38 M
0.2
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $24.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Market Value

$ 5.05 B

Holdings

114

Period

Q1 2026

Holdings in Top 20

61.1 %

QoQ Changes

2.98 %

Top 20 Holdings